These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 29901126)
1. Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines. Zhang Y; Ge Y; Ping X; Yu M; Lou D; Shi W Mol Med Rep; 2018 Aug; 18(2):1835-1841. PubMed ID: 29901126 [TBL] [Abstract][Full Text] [Related]
2. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642 [TBL] [Abstract][Full Text] [Related]
3. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Kauntz H; Bousserouel S; Gossé F; Raul F Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452 [TBL] [Abstract][Full Text] [Related]
4. Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells. Zhang Y; Li Q; Ge Y; Chen Y; Chen J; Dong Y; Shi W Phytother Res; 2013 Mar; 27(3):397-403. PubMed ID: 22619007 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. Pashaei-Asl F; Pashaei-Asl R; Khodadadi K; Akbarzadeh A; Ebrahimie E; Pashaiasl M Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1483-1487. PubMed ID: 28884602 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells. Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602 [TBL] [Abstract][Full Text] [Related]
7. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition. Wang YX; Cai H; Jiang G; Zhou TB; Wu H Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines. Doğan Şiğva ZÖ; Balci Okcanoğlu T; Biray Avci Ç; Yilmaz Süslüer S; Kayabaşi Ç; Turna B; Dodurga Y; Nazli O; Gündüz C Gene; 2019 Mar; 687():261-271. PubMed ID: 30453074 [TBL] [Abstract][Full Text] [Related]
9. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells. Kim S; Lee HS; Lee SK; Kim SH; Hur SM; Kim JS; Kim JH; Choe JH; Shin I; Yang JH; Lee JE; Nam SJ Phytomedicine; 2010 Dec; 17(14):1127-32. PubMed ID: 20554189 [TBL] [Abstract][Full Text] [Related]
10. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451 [TBL] [Abstract][Full Text] [Related]
11. Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC‑7901 human gastric cancer cells. Chen Y; Zhu L; Yang X; Wei C; Chen C; He Y; Ji Z Mol Med Rep; 2017 Nov; 16(5):6821-6827. PubMed ID: 28901518 [TBL] [Abstract][Full Text] [Related]
12. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1. Sutter AP; Maaser K; Grabowski P; Bradacs G; Vormbrock K; Höpfner M; Krahn A; Heine B; Stein H; Somasundaram R; Schuppan D; Zeitz M; Scherübl H J Hepatol; 2004 Nov; 41(5):799-807. PubMed ID: 15519653 [TBL] [Abstract][Full Text] [Related]
13. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death. Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029 [TBL] [Abstract][Full Text] [Related]
14. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer. Kang SK; Bae HJ; Kwon WS; Kim TS; Kim KH; Park S; Yu SY; Hwang J; Park J; Chung HC; Rha SY Cell Oncol (Dordr); 2021 Dec; 44(6):1387-1403. PubMed ID: 34791636 [TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis. Park ST; Byun HJ; Kim BR; Dong SM; Park SH; Jang PR; Rho SB Biochem Biophys Res Commun; 2013 May; 435(1):153-9. PubMed ID: 23628417 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921 [TBL] [Abstract][Full Text] [Related]
18. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells. Zhou L; Liu P; Chen B; Wang Y; Wang X; Chiriva Internati M; Wachtel MS; Frezza EE Anticancer Res; 2008; 28(2A):1119-27. PubMed ID: 18507063 [TBL] [Abstract][Full Text] [Related]
19. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. Fan L; Ma Y; Liu Y; Zheng D; Huang G Eur J Pharmacol; 2014 Nov; 743():79-88. PubMed ID: 25242120 [TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells. Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]